Health TrialsbyHealthPanel

Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers

ConditionsGastrostomyGastricGastroEsophageal Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center

About this trial

To compare the symptoms of patients who have a MIPG to the symptoms of patients who have a MITG.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Able to speak and read English, Spanish, Japanese or Korean

Participants with a biopsy-confirmed diagnosis of non-metastatic gastric or GEJ adenocarcinoma, who are scheduled to undergo MIPG or MITG for curative-intention

Age ≥ 18

Participants with known malabsorption syndromes or a lack of physical integrity of the upper gastrointestinal tract

Disqualifiers

None

Trial population

M D Anderson Cancer Center

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Standard of Care

    Other intervention

    complete a questionnaire within 30 days before your surgery and then at 1, 3, 6, and 12 months after surgery

  • Control Group

    Other intervention

    complete a questionnaire within 30 days before your surgery and then at 1, 3, 6, and 12 months after surgery

Treatment groups

20 Participants
are divided into 2 treatment groups
Group A: Standard of Care1 intervention
Group B: Control group1 intervention

Trial outcomes

Primary outcomes

1

(MDASI-GI) MD Anderson Symptom Inventory Questionnaire

Appetite level (reported on a 0-10 scale, in Q8 of MDASI-GI) scale 0-not present-10 as bad as you can image

Time frame
3 months after surgery

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

M.D. Anderson Cancer Center

Lead sponsor

Source ClinicalTrials.gov
Apply now